RxDoctor Payments Data

Owais Abdul Kafi, MD

Interventional Cardiology · Lake Forest, ILNPI 1922462647

Payments from drug & device makers

What this record shows

This record is dominated by grants: $47,500 of the $56,047 with a category attached, or 84.7%. Medtronic accounts for 63.6% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2024 at $46,609 and has fallen 97.3% since, to $1,280 in 2025. Among interventional cardiology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,047in general payments, 2019–2025

Across 124 payments — averaging $451.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$36K
  • Abbott$14K
  • Edwards Lifesciences$2K
  • Inari Medical, Inc.$1K
  • Boston Scientific$974
  • Abiomed$513
  • plus $2K from 15 others

What the payments were for

  • Grants$47,50085%
  • Travel & lodging$1,7333%
  • Food & beverage$6,37111%
  • Education$4431%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,047 in reported general payments places this provider in the 90th percentile of 303 interventional cardiology providers in Illinois.

See all interventional cardiology providers in Illinois

Medicare billing

Part B allowed, 2024
$22,246
Medicare patients
115
Services billed
222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate22$484
ClopidogrelClopidogrel Bisulfate22$300
Carvedilol21$141
Furosemide17$123
Atorvastatin Calcium17$96
Warfarin Sodium22$88
Amlodipine Besylate13$59

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Lake Forest

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →